Cargando…

Follow-up of hypertension in patients with multiple sclerosis

Detalles Bibliográficos
Autor principal:	Baghbanian, Seyed Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2016
Materias:	Clinical Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027156/ https://www.ncbi.nlm.nih.gov/pubmed/27648182

Ejemplares similares

Influenza vaccination in patients with multiple sclerosis is possible with some considerations
por: Baghbanian, Seyed Mohammad
Publicado: (2016)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Bullous pemphigoid as an injection site reaction of glatiramer acetate
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2019)

Evaluation of Urinary Tract Infection following Corticosteroid Therapy in Patients with Multiple Sclerosis Exacerbation
por: Bazi, Aliyeh, et al.
Publicado: (2021)

Atypical molluscum contagiosum on multiple sclerosis patients treated with fingolimod: A case report
por: Cheraghmakani, Hamed, et al.
Publicado: (2022)

Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Beta-thalassemia intermedia with ischemic transients misdiagnosed as multiple sclerosis: A case report
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis
por: Brannigan, Jamie, et al.
Publicado: (2020)

Relationship between medical history and multiple sclerosis: A-case-control study
por: esfandiari, Fatemeh, et al.
Publicado: (2023)

Disaster and Multiple Sclerosis: A Systematic Review
por: HabibiSaravi, Reza, et al.
Publicado: (2022)

The effectiveness of amantadine and dalfampridine in improving fatigue in patients with multiple sclerosis: A randomized, double-blind, clinical trial
por: Sadeqi, Yasaman, et al.
Publicado: (2022)

Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models
por: Hosseinnataj, Abolfazl, et al.
Publicado: (2023)

How to make a decision on the choice of therapy for multiple sclerosis with sarcoidosis comorbidity?
por: Miletic-Drakulic, Svetlana D., et al.
Publicado: (2022)

Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy
por: Gattringer, Thomas, et al.
Publicado: (2014)

Disseminated Histoplasmosis in a Patient With Multiple Sclerosis Treated With Fingolimod
por: Abrahamowicz, Aleksandra A., et al.
Publicado: (2021)

Natalizumab Promotes Activation of Peripheral Monocytes in Patients With Multiple Sclerosis
por: Frisch, Esther S., et al.
Publicado: (2023)

Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate
por: Baharnoori, Moogeh, et al.
Publicado: (2016)

COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
por: Barzegar, Mahdi, et al.
Publicado: (2020)

Lymphopenia in treatment-naive relapsing multiple sclerosis
por: Lim, Zhi Wei, et al.
Publicado: (2016)

Initial clinical presentation of multiple sclerosis with concurrent COVID-19 infection: Case report and literature review
por: Ebadi, Zahra, et al.
Publicado: (2022)

Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate
por: Ma, Brandy B., et al.
Publicado: (2016)

Brain tuberculoma: Report of a case presented with prolonged nonspecific symptoms and multiple brain tuberculoma
por: Togha, Mansoureh, et al.
Publicado: (2012)

Age and sex-adjusted incidence and yearly prevalence of multiple sclerosis (MS) in Mazandaran province, Iran: An 11-years study
por: Cheraghmakani, Hamed, et al.
Publicado: (2020)

Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2020)

Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL
por: Schuh, Elisabeth, et al.
Publicado: (2014)

Monozygotic twins discordant for narcolepsy type 1 and multiple sclerosis
por: Jennum, Poul J., et al.
Publicado: (2016)

Characteristics of COVID-19 in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Interferon beta-1b-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) in a patient treated for multiple sclerosis: A case report
por: Etemadifar, Masoud, et al.
Publicado: (2018)

CNS inflammation other than multiple sclerosis: How likely is diagnosis?
por: Street, Duncan, et al.
Publicado: (2014)

Refractory chronic spontaneous urticaria after the use of alemtuzumab in multiple sclerosis
por: Hu, Hannah, et al.
Publicado: (2020)

4H leukodystrophy: Mild clinical phenotype and comorbidity with multiple sclerosis
por: DeGasperis, Stephanie M., et al.
Publicado: (2020)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

Glial Cells Express Nuclear Nrf2 After Fumarate Treatment for Multiple Sclerosis and Psoriasis
por: Metz, Imke, et al.
Publicado: (2015)

Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis
por: Thebault, Simon, et al.
Publicado: (2023)

Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
por: Palomares Cabeza, Virginia, et al.
Publicado: (2022)

Aggressive Herpes Zoster in Young Patients With Multiple Sclerosis Under Dimethyl Fumarate: Significance of CD8(+) and Natural Killer Cells
por: Anagnostouli, Maria C., et al.
Publicado: (2021)

Fatal acute liver failure with hepatitis B virus infection during nataluzimab treatment in multiple sclerosis
por: Hillen, Machteld E., et al.
Publicado: (2015)

Iranian specialists’ approach to surgery in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Can multiple system atrophy clinically be misdiagnosed as corticobasal syndrome in the early stages?
por: Saeedi, Yasaman, et al.
Publicado: (2021)

Exome sequencing of multiple-sclerosis patients and their unaffected first-degree relatives
por: Garcia-Rosa, Sheila, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_95cb4rf83nr4roulhme2mn03r2